Back to top
more

Delaware Healthcare Fund Class A: (MF: DLHAX)

(NASDAQ Mutual Funds) As of Apr 20, 2018 08:15 PM ET

 Add to portfolio

$23.15 USD

-0.22 (-0.94%)

Zacks MF Rank 2-Buy   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Mar 31, 2018

Total Return %* Percentile Rank Objective
YTD 1.07 34
3 months 1.07 34
6 months 2.35 20
1 Year 21.56 5
3 Year 10.01 1
5 Year 16.35 22
10 Year 18.31 3

* Annual for three years and beyond.

Zacks Premium Research for DLHAX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 28.95
% Yield 2.81
% SEC Yield
Net Assets (Mil $) 3/31/2018 212.77
%Turnover 3/31/2018 29.00

Risk

3 Year 5 Year 10 Year
Beta 1.10 0.99 0.94
Alpha -1.25 3.28 9.14
R Squared 0.65 0.57 0.68
Std. Dev. 13.92 12.92 17.09
Sharpe 0.75 1.31 1.00

Sector / Country Weightings

As of 3/31/2018 % of Portfolio
Health 44.57
Other 24.51
Industrial Cyclical 9.25
Finance 8.59
Services 4.32
Technology 4.30
Retail Trade 2.95
Non-Durable 1.51

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2017)
% of Portfolio Value (Mil$)
MORPHOSYS AG 8.11 37.47
SANOFI ADR 7.82 36.14
CHUGAI PHARMACEUTICAL LTD 6.63 30.67
ELI LILLY & CO 3.84 17.74
PFIZER INC 3.12 14.42
SOHU.COM 3.00 13.87
AMGEN INC 2.90 13.39
ABBVIE INC 2.72 12.57
BOSTON SCIENTIFIC CORP 2.68 12.40

Stock Holding % of Net Assets

As Of 12/31/2017
Total Issues 69
Avg. P/E 30.13
Avg. P/Book 6.19
Avg. EPS Growth 15.9
Avg. Market Value (Mil $) 55,850

Allocation

% of Portfolio
Large Growth 28.71
Large Value 22.60
Small Growth 15.39
Small Value 0.00
Foreign Stock 12.70
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00